Eqis Capital Management, Inc. Teva Pharmaceutical Industries LTD Transaction History

Eqis Capital Management, Inc.

$1.17 Billion
Q2 2024

A detailed history of Eqis Capital Management, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 34,650 shares of TEVA stock, worth $606,375. This represents 0.05% of its overall portfolio holdings.

Number of Shares

34,650

Holding current value

$606,375

% of portfolio

0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$12.78 - $17.4 $442,827 - $602,910	34,650 New	34,650 $563,000
Q1 2021 May 14, 2021	SELL	$10.34 - $12.81 $113,884 - $141,089	-11,014 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$8.61 - $11.04 $56,894 - $72,952	-6,608 Reduced 37.5%	11,014 $106,000
Q3 2020 Nov 10, 2020	SELL	$8.57 - $12.69 $176,790 - $261,782	-20,629 Reduced 53.93%	17,622 $159,000
Q2 2020 Aug 10, 2020	BUY	$8.12 - $13.12 $136,984 - $221,334	16,870 Added 78.9%	38,251 $472,000
Q1 2020 May 12, 2020	BUY	$6.69 - $13.45 $1,893 - $3,806	283 Added 1.34%	21,381 $260,000
Q4 2019 Jan 24, 2020	BUY	$6.53 - $10.72 $36,920 - $60,610	5,654 Added 36.61%	21,098 $207,000
Q3 2019 Nov 05, 2019	SELL	$6.16 - $9.6 $15,338 - $23,904	-2,490 Reduced 13.88%	15,444 $106,000
Q2 2019 Jul 18, 2019	SELL	$8.12 - $15.72 $15,972 - $30,921	-1,967 Reduced 9.88%	17,934 $166,000
Q1 2019 Apr 18, 2019	BUY	$15.58 - $20.01 $5,608 - $7,203	360 Added 1.84%	19,901 $312,000
Q4 2018 Jan 25, 2019	SELL	$14.59 - $23.84 $20,834 - $34,043	-1,428 Reduced 6.81%	19,541 $301,000
Q3 2018 Oct 17, 2018	BUY	$21.06 - $25.65 $7,539 - $9,182	358 Added 1.74%	20,969 $476,000
Q2 2018 Jul 27, 2018	BUY	$16.77 - $24.71 $345,646 - $509,297	20,611 New	20,611 $501,000

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account

Eqis Capital Management, Inc. Teva Pharmaceutical Industries LTD Transaction History